| GeneMatcher: a matching tool for connecting investigators with an interest in the same gene | Human Mutation | 2015 | 716 |
| Modeling Linkage Disequilibrium Increases Accuracy of Polygenic Risk Scores | American Journal of Human Genetics | 2015 | 649 |
| Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies | Human Molecular Genetics | 2015 | 604 |
| The Genetic Basis of Mendelian Phenotypes: Discoveries, Challenges, and Opportunities | American Journal of Human Genetics | 2015 | 432 |
| Nosology and classification of genetic skeletal disorders: 2015 revision | American Journal of Medical Genetics, Part A | 2015 | 380 |
| Dynamic consent: a patient interface for twenty-first century research networks | European Journal of Human Genetics | 2015 | 355 |
| The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations | Human Mutation | 2015 | 338 |
| Oncotator: cancer variant annotation tool | Human Mutation | 2015 | 332 |
| The genetic ancestry of African Americans, Latinos, and European Americans across the United States | American Journal of Human Genetics | 2015 | 329 |
| Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1 | American Journal of Medical Genetics, Part A | 2015 | 321 |
| Th17-type cytokines, IL-6 and TNF-α synergistically activate STAT3 and NF-kB to promote colorectal cancer cell growth | Oncogene | 2015 | 300 |
| Differentiation of tumour-promoting stromal myofibroblasts by cancer exosomes | Oncogene | 2015 | 296 |
| The landscape and therapeutic relevance of cancer-associated transcript fusions | Oncogene | 2015 | 294 |
| Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents | American Journal of Human Genetics | 2015 | 280 |
| The Matchmaker Exchange: a platform for rare disease gene discovery | Human Mutation | 2015 | 280 |
| Non-coding genetic variants in human disease | Human Molecular Genetics | 2015 | 276 |
| PIK3CA-related overgrowth spectrum (PROS): diagnostic and testing eligibility criteria, differential diagnosis, and evaluation | American Journal of Medical Genetics, Part A | 2015 | 275 |
| HSPB1 as a novel regulator of ferroptotic cancer cell death | Oncogene | 2015 | 257 |
| Prenatal exposure to maternal smoking and offspring DNA methylation across the lifecourse: findings from the Avon Longitudinal Study of Parents and Children (ALSPAC) | Human Molecular Genetics | 2015 | 256 |
| Cell death by autophagy: emerging molecular mechanisms and implications for cancer therapy | Oncogene | 2015 | 242 |
| Junk DNA and the long non-coding RNA twist in cancer genetics | Oncogene | 2015 | 231 |
| Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing | Human Molecular Genetics | 2015 | 225 |
| Ribonucleotide reductase and cancer: biological mechanisms and targeted therapies | Oncogene | 2015 | 223 |
| Genomic analyses reveal mutational signatures and frequently altered genes in esophageal squamous cell carcinoma | American Journal of Human Genetics | 2015 | 222 |
| TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells | Oncogene | 2015 | 222 |
